These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 12501923

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A review of vaccine research and development: tuberculosis.
    Girard MP, Fruth U, Kieny MP.
    Vaccine; 2005 Dec 30; 23(50):5725-31. PubMed ID: 16153751
    [Abstract] [Full Text] [Related]

  • 8. Tuberculosis one century after R. Koch.
    Telenti A.
    Schweiz Med Wochenschr; 1998 Jan 17; 128(3):80-3. PubMed ID: 9498259
    [Abstract] [Full Text] [Related]

  • 9. [Immunology of tuberculosis and current status of vaccine development].
    Ulrichs T.
    Pneumologie; 2008 Mar 17; 62(3):143-7. PubMed ID: 18320494
    [Abstract] [Full Text] [Related]

  • 10. Detection of multidrug resistance in Mycobacterium tuberculosis.
    Sekiguchi J, Miyoshi-Akiyama T, Augustynowicz-Kopeć E, Zwolska Z, Kirikae F, Toyota E, Kobayashi I, Morita K, Kudo K, Kato S, Kuratsuji T, Mori T, Kirikae T.
    J Clin Microbiol; 2007 Jan 17; 45(1):179-92. PubMed ID: 17108078
    [Abstract] [Full Text] [Related]

  • 11. [Mycobacterium tuberculosis resistance to antitubercular agents in Antananarivo in 2000].
    Ratsirahonana O, Rasolofo Razanamparany V, Rasolonavalona T, Rakotonirina V, Rakotoarisaonina A, Rakotoherisoa A, Ralamboson M, Cauchoix B, Rakotondramarina D, Ramarokoto H.
    Arch Inst Pasteur Madagascar; 2002 Jan 17; 68(1-2):44-7. PubMed ID: 12643091
    [Abstract] [Full Text] [Related]

  • 12. [Some regularities of an immune response in patients with pulmonary tuberculosis and drug-resistant Mycobacterium strains].
    Sakharova IIa, Ariél' BM, Knoring BE, Skvortsova LA, Vasil'eva GIu, Vishnevskiĭ BI, Pogodaeva SS.
    Probl Tuberk Bolezn Legk; 2008 Jan 17; (12):22-7. PubMed ID: 19230184
    [Abstract] [Full Text] [Related]

  • 13. Systems-level modeling of mycobacterial metabolism for the identification of new (multi-)drug targets.
    Rienksma RA, Suarez-Diez M, Spina L, Schaap PJ, Martins dos Santos VA.
    Semin Immunol; 2014 Dec 17; 26(6):610-22. PubMed ID: 25453232
    [Abstract] [Full Text] [Related]

  • 14. What we can learn from the Mycobacterium tuberculosis genome sequencing projects.
    Manabe YC, Dannenberg AM, Bishai WR.
    Int J Tuberc Lung Dis; 2000 Feb 17; 4(2 Suppl 1):S18-23. PubMed ID: 10688144
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Tuberculosis vaccine research: the impact of immunology.
    Barker LF, Brennan MJ, Rosenstein PK, Sadoff JC.
    Curr Opin Immunol; 2009 Jun 17; 21(3):331-8. PubMed ID: 19505813
    [Abstract] [Full Text] [Related]

  • 17. Tuberculosis: from genome to vaccine.
    de Jonge MI, Brosch R, Brodin P, Demangel C, Cole ST.
    Expert Rev Vaccines; 2005 Aug 17; 4(4):541-51. PubMed ID: 16117711
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Further acquisition of drug-resistance in multidrug-resistant tuberculosis during chemotherapy.
    Toyota E, Sekiguchi J, Shimizu H, Fujino T, Otsuka Y, Yoshikura H, Kuratsuji T, Kirikae T, Kudo K.
    Jpn J Infect Dis; 2004 Dec 17; 57(6):292-4. PubMed ID: 15623961
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.